Ravuconazole is a broad-spectrum triazole antifungal agent designed to inhibit fungal cytochrome P450-dependent 14α-lanosterol demethylase, thereby treating serious fungal infections such as invasive aspergillosis… Read more










Ravuconazole is a broad-spectrum triazole antifungal agent designed to inhibit fungal cytochrome P450-dependent 14α-lanosterol demethylase, thereby treating serious fungal infections such as invasive aspergillosis and esophageal candidiasis. Laboratories and researchers utilize this collection of Ravuconazole-related compounds for comprehensive analytical testing, method validation, and rigorous quality control protocols. The inventory includes high-purity reference standards of the active pharmaceutical ingredient, alongside critical process-related impurities, stereoisomers, and stable isotope-labelled compounds. These materials are essential for accurate impurity profiling and quantitative analysis, particularly when developing sensitive detection methods like LC-MS/MS. By incorporating these labelled standards, analysts can correct for matrix effects and ensure consistent, reproducible results during the evaluation of drug substances and pharmaceutical formulations throughout their development and lifecycle.